Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

Cost-effectiveness of influenza vaccination of older adults in the ED setting.

Patterson BW, Khare RK, Courtney DM, Lee TA, Kyriacou DN.

Am J Emerg Med. 2012 Sep;30(7):1072-9. doi: 10.1016/j.ajem.2011.07.007. Epub 2011 Sep 9.

PMID:
21908140
[PubMed - indexed for MEDLINE]
2.

Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.

Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ.

Am J Prev Med. 2006 Jul;31(1):72-9. Review.

PMID:
16777545
[PubMed - indexed for MEDLINE]
3.

Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group.

Newall AT, Kelly H, Harsley S, Scuffham PA.

Pharmacoeconomics. 2009;27(6):439-50. doi: 10.2165/00019053-200927060-00001. Review.

PMID:
19640008
[PubMed - indexed for MEDLINE]
4.

Antiviral agents for influenza: a comparison of cost-effectiveness data.

Lynd LD, Goeree R, O'Brien BJ.

Pharmacoeconomics. 2005;23(11):1083-106. Review.

PMID:
16277546
[PubMed - indexed for MEDLINE]
5.

Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.

Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA.

Drugs. 2012 Jan 1;72(1):35-48. doi: 10.2165/11597310-000000000-00000. Review.

PMID:
22191794
[PubMed - indexed for MEDLINE]
6.
7.

Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K.

Health Technol Assess. 2003;7(35):iii-iv, xi-xiii, 1-170. Review.

PMID:
14609480
[PubMed - indexed for MEDLINE]
Free Article
8.

Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.

Postma MJ, Jansema P, van Genugten ML, Heijnen ML, Jager JC, de Jong-van den Berg LT.

Drugs. 2002;62(7):1013-24. Review.

PMID:
11985488
[PubMed - indexed for MEDLINE]
9.

Influenza vaccines provide diminished protection but are cost-saving in older adults.

Deans GD, Stiver HG, McElhaney JE.

J Intern Med. 2010 Feb;267(2):220-7. doi: 10.1111/j.1365-2796.2009.02201.x. Review.

PMID:
20175868
[PubMed - indexed for MEDLINE]
10.

Economic evaluation of influenza vaccination. Assessment for The Netherlands.

Postma MJ, Bos JM, van Gennep M, Jager JC, Baltussen R, Sprenger MJ.

Pharmacoeconomics. 1999;16 Suppl 1:33-40. Review.

PMID:
10623374
[PubMed - indexed for MEDLINE]
11.

Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.

Saborido CM, Hockenhull J, Bagust A, Boland A, Dickson R, Todd D.

Health Technol Assess. 2010 Jun;14(31):iii-iv, 1-75. doi: 10.3310/hta14310. Review.

PMID:
20569652
[PubMed - indexed for MEDLINE]
Free Article
12.

Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy.

Myers ER, Misurski DA, Swamy GK.

Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S128-40. doi: 10.1016/j.ajog.2011.04.009. Epub 2011 Apr 15. Review.

PMID:
21640230
[PubMed - indexed for MEDLINE]
13.

[Pharmaco-economics of anti-influenza vaccinations].

Jahnz-Rózyk K.

Pol Merkur Lekarski. 2003 Jun;14(84):679-81. Review. Polish.

PMID:
14524303
[PubMed - indexed for MEDLINE]
14.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk